CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,800,629
-47.4%
756,567
+5.9%
0.00%0.0%
Q2 2023$3,421,349
-4.8%
714,269
+12.7%
0.00%0.0%
Q1 2023$3,594,037
+0.8%
633,869
-0.5%
0.00%0.0%
Q4 2022$3,566,629
-10.9%
636,898
+2.2%
0.00%0.0%
Q3 2022$4,001,000
+147.4%
623,060
+32.2%
0.00%0.0%
Q2 2022$1,617,000
-52.9%
471,388
-2.2%
0.00%0.0%
Q1 2022$3,434,000
-12.4%
482,178
+2.5%
0.00%0.0%
Q4 2021$3,918,000
+20.8%
470,292
+0.9%
0.00%0.0%
Q3 2021$3,243,000
-67.6%
465,883
+10.9%
0.00%
-66.7%
Q2 2021$10,021,000
+27.3%
420,165
+9.9%
0.00%0.0%
Q1 2021$7,874,000
-13.7%
382,377
+2.7%
0.00%
-25.0%
Q4 2020$9,122,000
-6.0%
372,308
+8.6%
0.00%0.0%
Q3 2020$9,702,000
+390.0%
342,693
-17.6%
0.00%
+300.0%
Q2 2020$1,980,000
+42.3%
415,888
+6.8%
0.00%0.0%
Q1 2020$1,391,000
+4.7%
389,467
+1.2%
0.00%0.0%
Q4 2019$1,328,000
-13.2%
384,909
+0.9%
0.00%0.0%
Q3 2019$1,530,000
+70.6%
381,413
+36.9%
0.00%0.0%
Q2 2019$897,000
-3.7%
278,550
+105.6%
0.00%0.0%
Q1 2019$931,000
+69.3%
135,499
+11.4%
0.00%
Q4 2018$550,000
-40.9%
121,585
-0.7%
0.00%
-100.0%
Q3 2018$930,000
-7.8%
122,493
+4.5%
0.00%0.0%
Q2 2018$1,009,000
+39.2%
117,255
+18.8%
0.00%0.0%
Q1 2018$725,000
-25.2%
98,693
+3.3%
0.00%0.0%
Q4 2017$969,000
-41.5%
95,534
-7.5%
0.00%0.0%
Q3 2017$1,657,000
+60.1%
103,286
+12.8%
0.00%0.0%
Q2 2017$1,035,000
+0.8%
91,543
+0.5%
0.00%0.0%
Q1 2017$1,027,000
+19.7%
91,049
+5.1%
0.00%0.0%
Q4 2016$858,000
+11.4%
86,603
+38.3%
0.00%0.0%
Q3 2016$770,000
-32.9%
62,599
+58.6%
0.00%0.0%
Q2 2016$1,147,000
+83.8%
39,470
+68.0%
0.00%0.0%
Q1 2016$624,000
-22.9%
23,492
+2.0%
0.00%0.0%
Q4 2015$809,000
+74.7%
23,033
+47.6%
0.00%0.0%
Q3 2015$463,00015,6100.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 12,682,876$93,092,00026.99%
ARK Investment Management 2,406,723$17,665,0000.88%
Virtus ETF Advisers LLC 76,713$563,0000.49%
Bison Wealth, LLC 33,929$249,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,525$143,0000.10%
Rock Springs Capital Management LP 220,000$1,615,0000.07%
FEDERATED HERMES, INC. 1,766,681$12,968,0000.04%
Spark Investment Management LLC 79,500$583,0000.04%
A.R.T. Advisors, LLC 45,952$337,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 88,684$651,0000.01%
View complete list of SERES THERAPEUTICS INC shareholders